A Welcome from the Editorial Board
Biology of ADA-SCID
Biodistribution analyses of ADA retroviral vector detailed
Long-term enzyme replacement therapy feasible in ADA-deficient patients
Cytoreductive conditioning intensity linked to post-gene therapy clonal, TCR diversity
Neurological, behavioural defects an intrinsic manifestation of ADA deficiency
Annual autumn meeting of the Inborn Errors Working Party.
The third edition of the International Primary Immunodeficiencies Congress